InvestorsHub Logo
Followers 5
Posts 213
Boards Moderated 0
Alias Born 08/19/2013

Re: Darwinian post# 1816

Wednesday, 02/25/2015 10:46:41 AM

Wednesday, February 25, 2015 10:46:41 AM

Post# of 3806
From the presentation they are expecting enrolment to take a year. Expecting last patient last visit Aug 2017.
The shorter FX trial should hopefully be long enough to see the true effect of this drug. The Cohort 3 FibroScan showed greatly improving results with increasing time 2 patients were noticed to have 50% drop and 1 with 30% after 60days. The FX trial will be twice as long with 9 doses vs 4.
Hopefully all 20 enrolled see a 50%+ drop and GALT can get Breakthrough designation. Get this drug to market as quickly as possible, so as to save as many lives as possible.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News